Problems with hydromorphone prescribing as a response to the opioid crisis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

1. Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.Harm reduction journal · 2022
   Pooled it
2. Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces.Canadian journal of public health = Revue canadienne de sante publique · 2023
   Article
3. Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.BMC health services research · 2023
   Article
4. Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
   Article
5. Initiations of safer supply hydromorphone increased during the COVID-19 pandemic in Ontario: An interrupted time series analysis.PloS one · 2023
   Article
6. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.PloS one · 2023
   Article
7. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
   Article
8. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada.The International journal on drug policy · 2022
   Article
9. Tackling the overdose crisis: The role of safe supply.The International journal on drug policy · 2020
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as